Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.
暂无分享,去创建一个
M. Chintagumpala | J. Dome | P. Grundy | E. Perlman | N. Daw | P. Ehrlich | L. Renfro | J. Geller | C. Fernandez | J. Kalapurakal | G. Khanna | E. Mullen | E. Gratias | D. Dix | Eric J. Gratias
[1] D. Green. Letter to the Editor: Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. , 2022, The Journal of the National Comprehensive Cancer Network.
[2] M. Chintagumpala,et al. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group , 2020, Cancer.
[3] James R. Anderson,et al. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Dome,et al. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. , 2019, European journal of cancer.
[5] James R. Anderson,et al. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] James R. Anderson,et al. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Chintagumpala,et al. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group , 2017, Annals of surgery.
[8] James R. Anderson,et al. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532 , 2017, Annals of surgery.
[9] James R. Anderson,et al. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. O'sullivan,et al. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Nakayama,et al. The History of Multimodal Treatment of Wilms’ Tumor , 2016, The American surgeon.
[12] K. Pritchard-Jones,et al. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] James R. Anderson,et al. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] James R. Anderson,et al. Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group , 2013, Cancer.
[15] James R. Anderson,et al. Children's Oncology Group's 2013 blueprint for research: Renal tumors , 2013, Pediatric blood & cancer.
[16] N. Breslow,et al. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. van Tinteren,et al. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] N. Breslow,et al. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies‐4 and ‐5: A report from the Children's Oncology Group , 2012, Pediatric blood & cancer.
[19] K. Pritchard-Jones,et al. The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study. , 2012, European journal of cancer.
[20] J. Dome,et al. Barriers to the Enrollment of Children in the Children's Oncology Group Study of Very Low Risk Wilms Tumor: A Report from the Children's Oncology Group , 2011, Journal of pediatric hematology/oncology.
[21] James R. Anderson,et al. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] N. Breslow,et al. Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5 , 2010, Annals of surgery.
[23] Norman Breslow,et al. Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features , 2009, Clinical Cancer Research.
[24] James R. Anderson,et al. Hepatic Metastasis at Diagnosis in Patients With Wilms Tumor is not an Independent Adverse Prognostic Factor for Stage IV Wilms Tumor: A Report From the Children's Oncology Group/National Wilms Tumor Study Group , 2009, Annals of surgery.
[25] N. Breslow,et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] N. Breslow,et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Green,et al. The treatment of stages I-IV favorable histology Wilms' tumor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] N. Breslow,et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] N. Breslow,et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] James R. Anderson,et al. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor : A Report From the Children ' s Oncology Group Study AREN 0532 , 2022 .